Search

Your search keyword '"Boulet, Louis-Philippe"' showing total 230 results

Search Constraints

Start Over You searched for: Author "Boulet, Louis-Philippe" Remove constraint Author: "Boulet, Louis-Philippe" Publication Year Range Last 3 years Remove constraint Publication Year Range: Last 3 years
230 results on '"Boulet, Louis-Philippe"'

Search Results

3. MASK-air: An OECD (Organisation for Economic Co-operation and Development) Best Practice for Public Health on Integrated Care for Chronic Diseases

4. Poor Rhinitis and Asthma Control Is Associated With Decreased Health-Related Quality of Life and Utilities: A MASK-air Study

8. Impact of Dyspnea on Adults With Respiratory Symptoms Without a Defined Diagnosis

9. Analysis of comorbidities and multimorbidity in adult patients in the International Severe Asthma Registry

10. Global access and patient safety in the transition to environmentally friendly respiratory inhalers: the Global Initiative for Asthma perspective

12. Development and validation of an electronic daily control score for asthma (e-DASTHMA): a real-world direct patient data study

14. Disease burden in individuals with symptomatic undiagnosed asthma or COPD

20. Effects of Traffic-Related Air Pollution on Exercise Endurance, Dyspnea, and Cardiorespiratory Responses in Health and COPD: A Randomized, Placebo-Controlled, Crossover Trial

21. Global Initiative for Asthma Strategy 2021: Executive Summary and Rationale for Key Changes

22. Poor rhinitis and asthma control is associated with decreased health-related quality-of-life and utilities: A MASK-air study

23. MASK-air®: An OECD (Organisation for Economic Coordination and Development) Best Practice for Public Health on integrated care for chronic diseases.

24. Defining a Severe Asthma Super-Responder: Findings from a Delphi Process

26. Relevance of individual bronchial symptoms for asthma diagnosis and control in patients with rhinitis:A MASK-air study

29. Prioritization of candidate causal genes for asthma in susceptibility loci derived from UK Biobank

30. Association Between T2-related Comorbidities and Effectiveness of Biologics in Severe Asthma

31. Impact of Undiagnosed COPD and Asthma on Symptoms, Quality of Life, Healthcare Utilization and Work Productivity

32. Identifying undiagnosed asthma in symptomatic adults with normal pre- and post-bronchodilator spirometry

33. Patient‐centered digital biomarkers for allergic respiratory diseases and asthma: The ARIA‐EAACI approach – ARIA‐EAACI Task Force Report

35. Impact of Undiagnosed Chronic Obstructive Pulmonary Disease and Asthma on Symptoms, Quality of Life, Healthcare Use, and Work Productivity.

36. Management of cough in Canadian primary care and specialty practices: A survey of current knowledge of clinicians and allied health professionals

38. Not just an anti-eosinophil drug:tezepelumab treatment for type 2 asthma and beyond

39. Patient-centered digital biomarkers for allergic respiratory diseases and asthma:The ARIA-EAACI approach – ARIA-EAACI Task Force Report

40. Patient‐centred digital biomarkers for allergic respiratory diseases and asthma: the ARIA‐EAACI approach

41. Development and validation of an electronic daily control score for asthma (e-DASTHMA):a real-world direct patient data study

42. Inhaled anti-TSLP antibody fragment, ecleralimab, blocks responses to allergen in mild asthma

45. Burden of Pertussis in Individuals with a Diagnosis of Asthma: A Retrospective Database Study in England

46. Sounding the alarmins—The role of alarmin cytokines in asthma

47. Criteria to evaluate efficacy of biologics in asthma: a Global Asthma Association survey

50. Patient and physician factors associated with symptomatic undiagnosed asthma or COPD

Catalog

Books, media, physical & digital resources